Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope

Journal of Psychosomatic Research

Volumn 67, Issue 3, 2009, Pages 213-222

  D'Antono, Bianca ^a,b,c   Dupuis, Gilles ^a,c   St Jean, Karine ^a,c   Lévesque, Karine ^a,c   Nadeau, Reginald ^b,d   Guerra, Peter ^a,b   Thibault, Bernard ^a,b   Kus, Teresa ^b,d  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Anxiety; Depression; Distress; Recurrent syncope; Vasovagal

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC VALUE; DISTRESS SYNDROME; FEMALE; HEAD TILTING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREDICTION; PROSPECTIVE STUDY; SYNCOPE;

EID: 67349287640     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2009.03.012     Document Type: Article

References (68)

1. Kenny R.A., Ingram A., Bayliss J., and Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1 (1986) 1352-1355
2. Parry S.W., and Kenny R.A. The management of vasovagal syncope. QJM 92 (1999) 697-705
3. Koenig D., Linzer M., Pontinen M., and Divine G.W. Syncope in young adults: evidence for a combined medical and psychiatric approach. J Intern Med 232 (1992) 169-176
4. Mohan L., and Lavania A.K. Vasovagal syncope: an enigma. J Assoc Physicians India 52 (2004) 301-304
5. Savage D.D., Corwin L., McGee D.L., Kannel W.B., and Wolf P.A. Epidemiologic features of isolated syncope: the Framingham Study. Stroke 16 (1985) 626-629
6. Krahn A.D., Klein G.J., Yee R., and Norris C. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol 82 (1998) 117-119
7. Farwell D.J., Freemantle N., and Sulke N. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J 27 (2006) 351-356
8. Soteriades E.S., Evans J.C., Larson M.G., Chen M.H., Chen L., Benjamin E.J., et al. Incidence and prognosis of syncope. N Engl J Med 347 (2002) 878-885
9. Lipsitz L.A., Wei J.Y., and Rowe J.W. Syncope in an elderly, institutionalised population: prevalence, incidence, and associated risk. Q J Med 55 (1985) 45-54
10. Ganzeboom K.S., Mairuhu G., Reitsma J.B., Linzer M., Wieling W., and van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 17 (2006) 1172-1176
11. Sheldon R. Role of pacing in the treatment of vasovagal syncope. Am J Cardiol 84 (1999) 26Q-32Q
12. Sheldon R. Pacing to prevent vasovagal syncope. Cardiol Clin 18 (2000) 81-93
13. Calkins H. Pharmacologic approaches to therapy for vasovagal syncope. Am J Cardiol 84 (1999) 20Q-25Q
14. Di Girolamo E., Di Iorio C., Leonzio L., Sabatini P., and Barsotti A. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents. Circulation 100 (1999) 1798-1801
15. White C.M., and Tsikouris J.P. A review of pathophysiology and therapy of patients with vasovagal syncope. Pharmacotherapy 20 (2000) 158-165
16. Day S.C., Cook E.F., Funkenstein H., and Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 73 (1982) 15-23
17. Gendelman H.E., Linzer M., Gabelman M., Smoller S., and Scheuer J. Syncope in a general hospital patient population. Usefulness of the radionuclide brain scan, electroencephalogram, and 24-hour Holter monitor. N Y State J Med 83 (1983) 1161-1165
18. Schillinger M., Domanovits H., Mullner M., Herkner H., and Laggner A.N. Admission for syncope: evaluation, cost and prognosis. Wien Klin Wochenschr 112 (2000) 835-841
19. Sun B.C., Emond J.A., and Camargo C.A. Direct medical costs of syncope-related hospitalizations in the United States. Am J Cardiol 95 (2005) 668-671
20. Eagle K.A., Black H.R., Cook E.F., and Goldman L. Evaluation of prognostic classifications for patients with syncope. Am J Med 79 (1985) 455-460
21. Kapoor W.N., Fortunato M., Hanusa B.H., and Schulberg H.C. Psychiatric illnesses in patients with syncope. Am J Med 99 (1995) 505-512
22. Linzer M., Felder A., Hackel A., Perry A.J., Varia I., Melville M.L., et al. Psychiatric syncope: a new look at an old disease. Psychosomatics 31 (1990) 181-188
23. Linzer M., Varia I., Pontinen M., Divine G.W., Grubb B.P., and Estes N.A. Medically unexplained syncope: relationship to psychiatric illness. Am J Med 92 (1992) 18-25
24. Oh J.H., and Kapoor W.N. Psychiatric illness and syncope. Cardiol Clin 15 (1997) 269-275
25. Ventura R., Maas R., Ruppel R., Stuhr U., Schuchert A., Meinertz T., et al. Psychiatric conditions in patients with recurrent unexplained syncope. Europace 3 (2001) 311-316
26. Kouakam C., Lacroix D., Baux P., Guedon-Moreau L., Klug D., Vaksmann G., et al. [Anxiety disorders and unexplained syncopes of presumed vaso-vagal origin]. Arch Mal Coeur Vaiss 89 (1996) 1247-1254
27. Cohen T.J., Thayapran N., Ibrahim B., Quan C., Quan W., and von zur Muhlen F. An association between anxiety and neurocardiogenic syncope during head-up tilt table testing. Pacing Clin Electrophysiol 23 (2000) 837-841
28. Giada F., Silvestri I., Rossillo A., Nicotera P.G., Manzillo G.F., and Raviele A. Psychiatric profile, quality of life and risk of syncopal recurrence in patients with tilt-induced vasovagal syncope. Europace 7 (2005) 465-471
29. McGrady A., Kern-Buell C., Bush E., Khuder S., and Grubb B.P. Psychological and physiological factors associated with tilt table testing for neurally mediated syncopal syndromes. Pacing Clin Electrophysiol 24 (2001) 296-301
30. Sledge W.H. Antecedent psychological factors in the onset of vasovagal syncope. Psychosom Med 40 (1978) 568-579
31. Sledge W.H., and Boydstun J.A. Syncope in aircrew. Aviat Space Environ Med 53 (1982) 258-265
32. Graham D.T. Prediction of fainting in blood donors. Circulation 23 (1961) 901-906
33. Kaloupek D.G., Scott J.R., and Khatami V. Assessment of coping strategies associated with syncope in blood donors. J Psychosom Res 29 (1985) 207-214
34. Kleinknecht R.A. Vasovagal syncope and blood/injury fear. Behav Res Ther 25 (1987) 175-178
35. Meade M.A., France C.R., and Peterson L.M. Predicting vasovagal reactions in volunteer blood donors. J Psychosom Res 40 (1996) 495-501
36. Kouakam C., Lacroix D., Klug D., Baux P., Marquié C., and Kacet S. Prevalence and prognostic significance of psychiatric disorders in patients evaluated for recurrent unexplained syncope. Am J Cardiol 89 (2002) 530-535
37. Spitzer R.L., Williams J.B., Kroenke K., Linzer M., deGruy F.V., Hahn S.R., et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272 (1994) 1749-1756
38. Ilfeld F.W. Further validation of a psychiatric symptom index in a normal population. Psychol Rep 39 (1976) 1215-1228
39. Préville M., Boyer R., Potvin L., Perrault C., and Légaré G. La détresse psychologique: détermination de la fiabilité et de la validité de la mesure utilisée dans l'enquête Santé Québec. Enquête Santé Québec 1987+, Cahier de Recherche No 7. Ministry of Health and Social Services (1992), Government of Quebec
40. Marchand L., Stephenson R., Feeney S., and Marchand A. Validation factorielle de l'adaptation canadienne-française de l'Anxiety Sensitivity Scale. Poster presented at the 67e Congrès annuel de l'Association Francophone pour le Savoir (ACFAS) (1999)
41. Reiss S., Peterson R.A., Gursky D.M., and McNally R.J. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24 (1986) 1-8
42. Verreault N., Labrecque J., Marchand A., and Marchand L. L'index de sensibilité à l'anxiété: une validation auprès de la population québécoise. Poster presented at the "28e congrès annuel de la Société québécoise pour la recherche en psychologie" (2006)
43. Arrindell W.A. Dimensional structure and psychopathology correlates of the Fear Survey Schedule (FSS-III) in a phobic population: a factorial definition of agoraphobia. Behav Res Ther 18 (1980) 229-242
44. Arrindell W.A., Eisemann M., Richter J., Oei T.P., Caballo V.E., van der Ende J., et al. Phobic anxiety in 11 nations. Part I: Dimensional constancy of the five-factor model. Behav Res Ther 41 (2003) 461-479
45. Wolpe J., and Lang P.J. A Fear Survey Schedule for Use in Behaviour Therapy. Behav Res Ther 2 (1964) 27-30
46. Arrindell W.A., Solyom C., Ledwidge B., van der Ende I., Hageman W.J.J.M., and Solyom L.Z. A. Cross-national validity of the five-components model of self-assessed fears: Canadian psychiatric outpatients data vs. Dutch target ratings on the Fear Survey Schedule-III. Adv Behav Res Ther 12 (1990) 101-122
47. Kenny R.A., O'Shea D., and Parry S.W. The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders. Heart 83 (2000) 564-569
48. Sutton R., and Bloomfield D.M. Indications, methodology, and classification of results of tilt-table testing. Am J Cardiol 84 (1999) 10Q-19Q
49. Gracie J., Newton J.L., Norton M., Baker C., and Freeston M. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope. Europace 8 (2006) 636-643
50. Andrighetto A.G., John Â., Barbisan J.N., and Vernet Taborda J.G. Medically unexplained syncope and its relationship to psychiatric disorders. Arq Bras Cardiol 72 (1999) 756-760
51. Linzer M., Pontinen M., Gold D.T., Divine G.W., Felder A., and Brooks W.B. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 44 (1991) 1037-1043
52. Brown T.A., O'Leary T.A., and Barlow D.H. General anxiety disorder. 2nd ed (2001), Guildford, New York
53. Craske M.G., and Barlow D.H. Panic and agorophobia. 2nd ed (2001), Guilford, New York
54. In: Moore R.G., and Garland A. (Eds). Cognitive therapy for chronic and persistent depression (2003), John Wiley & Sons, Chichester
55. Haynes R.B. Determinants of adherence: the disease and the mechanics of treatment (1979), John Hopkins University Press, Baltimore
56. Clancy J., and Noyes R. Anxiety neurosis: a disease for the medical model. Psychosomatics 17 (1976) 90-93
57. Katon W. Panic disorder: epidemiology, diagnosis, and treatment in primary care. J Clin Psychiatry 47 Suppl (1986) 21-30
58. Van Dijk N., Velzeboer S.C., Destree-Vonk A., Linzer M., and Wieling W. Psychological treatment of malignant vasovagal syncope due to blood phobia. Pacing Clin Electrophysiol 24 (2001) 122-124
59. Almquist A., Goldenberg I.F., Milstein S., Chen M.Y., Chen X.C., Hansen R., et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 320 (1989) 346-351
60. Athanasos P., Sydenham D., Latte J., Faunt J., and Tonkin A. Vasodepressor syncope and the diagnostic accuracy of the head-up tilt test with sublingual glyceryl trinitrate. Clin Auton Res 13 (2003) 453-455
61. Benditt D.G. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. Pacing Clin Electrophysiol 20 2 Pt 2 (1997) 572-584
62. Grubb B.P., and Kosinski D. Tilt table testing: concepts and limitations. Pacing Clin Electrophysiol 20 3 Pt 2 (1997) 781-787
63. Hegel M.T., Moore C.P., Collins E.D., Kearing S., Gillock K.L., Riggs R.L., et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 107 (2006) 2924-2931
64. Kalkman J.S., Schillings M.L., Zwarts M.J., van Engelen B.G., and Bleijenberg G. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I. Acta Neurol Scand 115 (2007) 265-270
65. Richmond T.S., Hollander J.E., Ackerson T.H., Robinson K., Gracias V., Shults J., et al. Psychiatric disorders in patients presenting to the emergency department for minor injury. Nurs Res 56 (2007) 275-282
66. Engel G.L. Psychologic stress, vasodepressor (vasovagal) syncope, and sudden death. Ann Intern Med 89 (1978) 403-412
67. Brody D.S., Khaliq A.A., and Thompson T.L. Patients' perspectives on the management of emotional distress in primary care settings. J Gen Intern Med 12 (1997) 403-406
68. Newton J.L., Kenny R.A., and Baker C.R. Cognitive behavioural therapy as a potential treatment for vasovagal/neurocardiogenic syncope-a pilot study. Europace 5 (2003) 299-301